Dr Suchitra Sundaram shares key highlights on frontline time limited and all oral regimens producing deep MRD responses, ...
The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...
The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting ...
The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.
Despite reported slowing of progression, regulators said the evidence on the novel oral agent blarcamesine did not support a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback